Primary Prevention Program

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The research program will have two parts: Stage1: identification of patients with moderate, high and very high cardiovascular risks, not having diseases of atherosclerotic genesis and requiring lipid‐lowering drugs. Stage 2: a prospective observation of patients receiving primary medical prophylaxis of CVD with atorvastatin
Epistemonikos ID: 491208c0e5a410f116cc4b9dc821c16db238b2c8
First added on: May 22, 2024